ZICCUM AB Half Year Report Q2 2019
Summary of Half Year Report second quarter 2019: This has been an eventful year for Ziccum.Summary of Half Year Report, second quarter 2019 2019 has been eventful for Ziccum: We have filed a patent application for an important component in the development of new vaccines, Adenovirus. This has resulted in several industrial players showing new interest in our technology. We also announced that we have entered into a Contract Research agreement with one of these companies, aimed at evaluating LaminarPace ™ in combination with their own project. In the second quarter we also got together